Brief: European Commission Grants SOBI Marketing Authorisation For Altuvoct For Treatment Of Haemophilia A
June 19 (Reuters) - Swedish Orphan Biovitrum AB (publ)
SOBIV.ST :
* EUROPEAN COMMISSION GRANTS SOBI MARKETING AUTHORISATION
FOR
ALTUVOCT FOR TREATMENT OF HAEMOPHILIA A
Source text for Eikon: ID:nPnbqb3K2a
Further company coverage: SOBIV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Swedish Orphan Biovitrum AB (publ)
See all newsTop of the Street: SOBI, Sonova, BAT, Imperial Brands
SOBI slips after Ionis lowers Tryngolza sales forecast
Brief: Swedish Orphan Biovitrum Executive Sells, Buys Shares
Europe Research Roundup: Centrica, Fuchs, URW
Brief: Swedish Orphan Biovitrum Proposes Börje Ekholm As New Chair And Board Member At 2027 AGM